Endo Tools Therapeutics

Based in Brussels, Belgium, Endo Tools Therapeutics develops specialized medical devices designed for minimally invasive therapeutic interventions within the field of gastroenterology. The company's flagship Endomina platform adds mechanical triangulation capabilities to existing standard endoscopes, enabling complex movements and multi-instrument utilization during endoscopic procedures for obesity, digestive tumors, and type II diabetes treatments. The hardware targets gastroenterologists, surgeons, and hospitals performing endoscopic procedures, aiming to reduce hospitalization times and limit broader capital investments. The enterprise has raised approximately $5.7 million in Series C financing to support ongoing commercialization efforts, and its proprietary devices have been utilized in over 230 clinical procedures. The medical device manufacturer is backed by lead investor Epimède and features a board of directors with ties to Lumine Capital, iSTAR Medical, and Abbott. Endo Tools Therapeutics was established in 2008 by an undisclosed founding team.